Advertisement

Topics

DCM Ventures Company Profile

02:59 EDT 20th June 2019 | BioPortfolio

DCM Ventures is a global venture capital firm based in Silicon Valley, Beijing, and Tokyo with more than $3 billion under management. DCM Ventures has invested in more than 300 early stage technology companies across the United States and Asia, and provides hands-on operational guidance and a global network of business and financial resources. DCM Ventures has backed industry leading companies including 51job, 51Talk, 58.com, About.com, BitAuto, Clearwire, Dangdang, eDreams, Fortinet, Happy Elements, Kakao Talk, Renren, Sling Media, Tuniu, and Vipshop. DCM Ventures has also invested in exciting, up and coming startups such as Bill.com, Careem, DerbySoft, DXY, Eaze, FiveStars, FreedomPop, Freee, FuboTV, Kuaishou, Musical.ly, Sansan, SoFi, SSqian, TanTan, Ucloud, and YouXinpai.


News Articles [254 Associated News Articles listed on BioPortfolio]

Patient relationship management startup Welkin Health raises $17.5M Series B round

Altos Ventures led the round while existing investors Thrive Capital, Red Swan Ventures and Asset Management Ventures also participated.

Redox Lands $33M for Scalable Healthcare Data Interoperability Platform

Redox, a Madison, WI-based company that is changing the way healthcare providers and software vendors share data has raised $33 million in Series C funding led by Battery Ventures. The Series C round ...

Unite Us Raises $35M for Care Coordination & Outcome Tracking Platform

Unite Us, a NYC-based care coordination and outcome tracking platform connecting healthcare and social service providers has raised $35 million in Series B funding. The funding round was led by Oak HC...

Kymera closes $65mm Series B round

Kymera Therapeutics Inc. (protein degradation-based drug discovery) raised $65mm through its Series B round. Bessemer Venture Partners, 6 Dimensions Capital, and Pfizer Venture Investments co-led and ...

The Importance of Funding Early Innovation. Roel Bulthuis, Head of MS Ventures.

MS Ventures is the strategic, corporate venture arm of the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. They invest globally in emerging biotechnology companies that develop products ...

Diameter Health Raises $9.6M to Expand Clinical Data Integration Platform

Strategic Investment Made by Optum Ventures Will Support Product and Marketing for Clinical Data Integration Platform Diameter Health, a Farmington, CT-based provider of clinical data integration solu...

PSJH spinout Xealth pulls in $11M for digital prescribing platform

The Series A funding came from a slew of investors, including Novartis, Philips, McKesson Ventures, ResMed, Providence Ventures and UPMC.

Checkerspot raises $13M Series A to produce biotech-enabled performance materials

Checkerspot, a biotech startup using microalgae to produce performance materials, announced today that it has closed its Series A financing for $13 million. The round was led by Builders VC, and inclu...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Psyche Meets the Gatekeepers: Creating a More Humane Culture for Women in Medicine.

In the Greek myth of Psyche and Eros, Psyche must fulfill four seemingly impossible tasks to achieve full consciousness before she can be reunited with her bridegroom, Eros. From early childhood, girl...

Beyond the Present Constraints That Prevent a Wide Spread of Tissue Engineering and Regenerative Medicine Approaches.

Despite the success of tissue engineered medical products (TEMPs) in preclinical translational research, very few have had success in the clinical market place. This gap, referred to as the "valley of...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation of a Digital Microscope for Malaria

Light microscopy, which is based on century-old technology, remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalaria...

Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)

Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...

Companies [597 Associated Companies listed on BioPortfolio]

GE Ventures

GE Ventures is committed to identifying, scaling and accelerating ideas that will make the world work better. Focused on the areas of software, advanced manufacturing, energy and ...

Extraordinary Ventures, Inc.

Founded in 2007 by a group of concerned parents, Extraordinary Ventures (EV) is a 501(c)(3) enterprise that creates and operates a portfolio of self-sustaining small, local busine...

Archytas Ventures, LLC

Archytas Ventures is a private, opportunistic investment holding company with offices in New York and Los Angeles. Archytas Ventures provides strategic capital solutions to the em...

Jina Ventures

Founded in 2003, Jina Ventures is a New York-based private equity and M&A advisory firm. Over the past 6 years, Jina Ventures has grown into a full service private equity practice, with both principal...

Rizk Ventures

Rizk Ventures is a privately-held investment firm based in New York, founded by Thomas A. Rizk and Linda Rizk. Rizk Ventures focuses on investment activities in the areas of Ventu...

More Information about "DCM Ventures" on BioPortfolio

We have published hundreds of DCM Ventures news stories on BioPortfolio along with dozens of DCM Ventures Clinical Trials and PubMed Articles about DCM Ventures for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DCM Ventures Companies in our database. You can also find out about relevant DCM Ventures Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record